PMBCL: Postremission, patients may safely skip radiationJune 6, 2023B Cell LymphomaDLBCLNon-Hodgkin Lymphoma
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Patient & Survivor CareDiversity in MedicineMixed TopicsDLBCLALLAMLAnemia
A 50-year-old White male presented with a 4- to 5-year history of progressively growing violaceous lesions on his left lower extremityApril 12, 2023B Cell Lymphoma
B-cell cancers: Sparse insight into preventing infectionsMarch 28, 2023CLLB Cell LymphomaMixed Topics
Erythema extent predicts death in cutaneous GVHDMarch 13, 2023TransplantMixed TopicsMultiple MyelomaCLLB Cell LymphomaMantle Cell Lymphoma
CAR T-cell therapy neurotoxicity linked to NfL elevationsOctober 3, 2022Cellular TherapyAggressive LymphomasALLB Cell LymphomaMultiple MyelomaMixed TopicsCLL
Phase 3 data: Zanubrutinib bests standard CLL treatmentAugust 16, 2022CLLMantle Cell LymphomaB Cell Lymphoma
